Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Injectable dexamethasone plus oral tamsulosin vs oral tamsulosin alone for pain reduction in small ureteral stones
IRCT20240809062704N1Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Mar 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of dexamethasone and tamsulosin in ureterolithiasis and nephrolithiasis (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoint: Pain reduction. Started Mar 2023; status: completed.
02
Drugs
dexamethasonetamsulosin
03
Conditions
ureterolithiasisnephrolithiasis
Beyond the preview
Go deeper on IRCT20240809062704N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240809062704N1.